BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23455394)

  • 1. Notch signaling in acute promyelocytic leukemia.
    Grieselhuber NR; Klco JM; Verdoni AM; Lamprecht T; Sarkaria SM; Wartman LD; Ley TJ
    Leukemia; 2013 Jul; 27(7):1548-1557. PubMed ID: 23455394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA mice.
    Wartman LD; Welch JS; Uy GL; Klco JM; Lamprecht T; Varghese N; Nagarajan R; Ley TJ
    PLoS One; 2012; 7(10):e46529. PubMed ID: 23056333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent
    Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M
    Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.
    Welch JS; Klco JM; Varghese N; Nagarajan R; Ley TJ
    Blood; 2011 Feb; 117(8):2460-8. PubMed ID: 21190992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
    Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
    Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice.
    Welch JS; Yuan W; Ley TJ
    J Clin Invest; 2011 Apr; 121(4):1636-45. PubMed ID: 21364283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
    Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
    Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.
    Dos Santos GA; Kats L; Pandolfi PP
    J Exp Med; 2013 Dec; 210(13):2793-802. PubMed ID: 24344243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel TNRC18-RARA fusion in acute promyelocytic leukemia lacking t(15;17)(q24;q12)/PML-RARA.
    Wang Z; Wen L; Zhang L; Xu X; Chen X; Yao L; Wang M; Shen Z; Mo G; Wang Y; Zhao D; Cai W; Shen J; Chi X; Xu Y; Zeng Z; Pan J; Ruan C; Wu D; Jia Z; Chen S
    Mol Carcinog; 2021 Feb; 60(2):. PubMed ID: 33428799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor function of Gata2 in acute promyelocytic leukemia.
    Katerndahl CDS; Rogers ORS; Day RB; Cai MA; Rooney TP; Helton NM; Hoock M; Ramakrishnan SM; Nonavinkere Srivatsan S; Wartman LD; Miller CA; Ley TJ
    Blood; 2021 Sep; 138(13):1148-1161. PubMed ID: 34125173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein.
    Li GH; Fan YZ; Liu XW; Zhang BF; Yin DD; He F; Huang SY; Kang ZJ; Xu H; Liu Q; Wu YL; Niu XL; Zhang L; Liu L; Hao MW; Han H; Liang YM
    Mol Cell Biochem; 2010 Jul; 340(1-2):7-14. PubMed ID: 20157766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dll1- and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells.
    Pellegrinet L; Rodilla V; Liu Z; Chen S; Koch U; Espinosa L; Kaestner KH; Kopan R; Lewis J; Radtke F
    Gastroenterology; 2011 Apr; 140(4):1230-1240.e1-7. PubMed ID: 21238454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.
    Gaillard C; Surianarayanan S; Bentley T; Warr MR; Fitch B; Geng H; Passegué E; de Thé H; Kogan SC
    Blood Adv; 2018 Oct; 2(19):2462-2466. PubMed ID: 30266821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia.
    Zeng CW; Chen ZH; Zhang XJ; Han BW; Lin KY; Li XJ; Wei PP; Zhang H; Li Y; Chen YQ
    Autophagy; 2014 Oct; 10(10):1726-37. PubMed ID: 25126724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro response to all-trans retinoic acid of acute promyelocytic leukemias with nonreciprocal PML/RARA or RARA/PML fusion genes.
    Mozziconacci MJ; Liberatore C; Brunel V; Grignani F; Arnoulet C; Ferrucci PF; Fernandez F; Sainty D; Pelicci PG; Birg F; Lafage-Pochitaloff M
    Genes Chromosomes Cancer; 1998 Jul; 22(3):241-50. PubMed ID: 9624536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo.
    Sjölund J; Johansson M; Manna S; Norin C; Pietras A; Beckman S; Nilsson E; Ljungberg B; Axelson H
    J Clin Invest; 2008 Jan; 118(1):217-28. PubMed ID: 18079963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for a functional role of bi-directional Notch signaling during angiogenesis.
    Liebler SS; Feldner A; Adam MG; Korff T; Augustin HG; Fischer A
    PLoS One; 2012; 7(12):e53074. PubMed ID: 23300864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
    Kelly LM; Kutok JL; Williams IR; Boulton CL; Amaral SM; Curley DP; Ley TJ; Gilliland DG
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8283-8. PubMed ID: 12060771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
    Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM
    Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.
    Matsushita H; Yahata T; Sheng Y; Nakamura Y; Muguruma Y; Matsuzawa H; Tanaka M; Hayashi H; Sato T; Damdinsuren A; Onizuka M; Ito M; Miyachi H; Pandolfi PP; Ando K
    PLoS One; 2014; 9(11):e111082. PubMed ID: 25369030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.